11,995
Views
21
CrossRef citations to date
0
Altmetric
RCT OF TWO COMBINATIONS OF MYO-INOSITOL AND D-CHIRO-INOSITOL IN PCOS UNDERGOING ICSI

Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial

, , , , , , , , & show all
Pages 695-700 | Received 01 Nov 2018, Accepted 02 Jan 2019, Published online: 16 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Keerthana Rajasekaran, Neena Malhotra, Reeta Mahey, Rajesh Khadgawat & Mani Kalaivani. (2022) Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study. Gynecological Endocrinology 38:2, pages 140-147.
Read now
Paolo Giovanni Artini, Maria Elena Rosa Obino, Elisabetta Micelli, Elisa Malacarne, Chiara Vacca, Francesca Papini & Vito Cela. (2020) Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women. Gynecological Endocrinology 36:9, pages 755-759.
Read now
Nicolas Mendoza, Maria Isabel Galan, Cristina Molina, Raquel Mendoza-Tesarik, Cristina Conde, Maryna Mazheika, Maria Paz Diaz-Ropero, Juristo Fonolla, Jan Tesarik & Monica Olivares. (2020) High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecological Endocrinology 36:5, pages 398-401.
Read now
Simone Garzon, Antonio Simone Laganà & Giovanni Monastra. (2019) Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 697-703.
Read now

Articles from other publishers (16)

Farah Ennab & William Atiomo. (2023) Obesity and female infertility. Best Practice & Research Clinical Obstetrics & Gynaecology 89, pages 102336.
Crossref
A. I. Turchinets, E. V. Uvarova, E. P. Khashchenko & Z. Kh. Kumykova. (2023) Target therapy of polycystic ovary syndrome. Meditsinskiy sovet = Medical Council:5, pages 7-13.
Crossref
M. S. Titova, M. I. Kolodina, A. S. Lyashenko & E. N. Lyashenko. (2022) Use of myo-inositol in women with polycystic ovary syndrome in the application of auxiliary reproductive technologies. Meditsinskiy sovet = Medical Council:16, pages 50-56.
Crossref
Garima Kachhawa, Krithika V. Senthil Kumar, Vidushi Kulshrestha, Rajesh Khadgawat, Reeta Mahey & Neerja Bhatla. (2021) Efficacy of myo‐inositol and d ‐chiro‐inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open‐label study . International Journal of Gynecology & Obstetrics 158:2, pages 278-284.
Crossref
Mariano Mascarenhas & Adam H. Balen. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 153 165 .
O.A. Nochvinа & E.V. Slyvka. (2021) Role of inositol and its isomers in glucose metabolism. REPRODUCTIVE ENDOCRINOLOGY:62, pages 104-109.
Crossref
Paolo Giovanni Artini, Elisa Malacarne & Vito Cela. (2021) PCOS and Assisted Reproduction Technique: Role and Relevance of Inositols. Endocrines 2:4, pages 515-522.
Crossref
Philippe Merviel, Pandora James, Sarah Bouée, Mathilde Le Guillou, Camille Rince, Charlotte Nachtergaele & Véronique Kerlan. (2021) Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive Health 18:1.
Crossref
Amerigo Vitagliano, Gabriel Cosmin Petre, Francesco Francini-Pesenti, Luca De Toni, Andrea Di Nisio, Giuseppe Grande, Carlo Foresta & Andrea Garolla. (2021) Dietary Supplements for Female Infertility: A Critical Review of Their Composition. Nutrients 13:10, pages 3552.
Crossref
Simona Dinicola, Vittorio Unfer, Fabio Facchinetti, Christophe O. Soulage, Nicholas D. Greene, Mariano Bizzarri, Antonio Simone Laganà, Shiao-Yng Chan, Arturo Bevilacqua, Lali Pkhaladze, Salvatore Benvenga, Annarita Stringaro, Daniele Barbaro, Marialuisa Appetecchia, Cesare Aragona, Maria Salomè Bezerra Espinola, Tonino Cantelmi, Pietro Cavalli, Tony T. Chiu, Andrew J. Copp, Rosario D’Anna, Didier Dewailly, Cherubino Di Lorenzo, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Moshe Hod, Zdravko Kamenov, Eleni Kandaraki, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Maurizio Nordio, Ali C. Ozay, Olga Papalou, Giuseppina Porcaro, Nikos Prapas, Scott Roseff, Monica Vazquez-Levin, Ivana Vucenik & Artur Wdowiak. (2021) Inositols: From Established Knowledge to Novel Approaches. International Journal of Molecular Sciences 22:19, pages 10575.
Crossref
Mohamed Abdel-Maboud, Amr Menshawy, Elfatih A. Hasabo, Mohamed Ibrahim Abdelraoof, Mohamed Alshandidy, Muhammad Eid, Esraa Menshawy, Oumaima Outani & Ahmed Menshawy. (2021) The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials. PLOS ONE 16:7, pages e0254412.
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Tatiana A. Oboskalova, Anna V. Vorontsova, Maksim A. Zvychainyi, Karina G. Gushchina & Marietta M. Maitesian. (2020) Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome. Gynecology 22:6, pages 84-89.
Crossref
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Olga A. Gromova, Ivan Yu. Torshin, Elena V. Uvarova, Natalya I. Tapilskaya & Alla G. Kalacheva. (2020) Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol. Gynecology 22:3, pages 21-28.
Crossref
Scott Roseff & Marta Montenegro. (2020) Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary. International Journal of Endocrinology 2020, pages 1-8.
Crossref